Literature DB >> 3704563

Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures.

H F Guiot, A V Helmig-Schurter, J W van der Meer, R van Furth.   

Abstract

To confirm the results obtained in an earlier study, the incidence of infection was evaluated in 54 patients (62 periods of admission), nursed in conventional rooms and given a regimen of antimicrobial agents intended to modulate the intestinal flora selectively as a method to prevent infection during severe granulocytopenia. In 62 patients receiving selective antimicrobial modulation (SAM), 18% acquired major infections which was similar to 19% in patients on SAM in an earlier double-blind placebo controlled study and lower than 47% in the controls. Evaluation of a large number of surveillance cultures showed that the presence of specific potentially pathogenic aerobic bacteria was associated with the occurrence of major infection. If the bacterial species in question were not found in the cultures the chance of becoming infected was less than 5%, whereas the chance ranged between 42 and 62% depending on the species involved when these microorganisms were isolated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3704563     DOI: 10.3109/00365548609032322

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

Review 1.  Modulation of the host flora.

Authors:  R van Furth; H F Guiot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

2.  Prolonged granulocytopenia due to selective antimicrobial modulation of the intestinal flora of irradiated mice: the impact on recovery from infection.

Authors:  H F Guiot; E F Tordoir-van der Bent; A V Helmig-Schurter
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

3.  Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.

Authors:  H F Guiot; J W van der Meer; P J van den Broek; R Willemze; R van Furth
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

4.  Isolation of vancomycin-resistant enterococci in haematologic patients.

Authors:  H F Guiot; W E Peetermans; F W Sebens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

5.  Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin.

Authors:  H F Guiot; W G Peters; P J van den Broek; J W van der Meer; J A Kramps; R Willemze; R van Furth
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia.

Authors:  W Kern; E Kurrle; E Vanek
Journal:  Klin Wochenschr       Date:  1987-08-17

Review 7.  Selective decontamination in bone marrow transplant recipients.

Authors:  H F Guiot; R van Furth
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

8.  The relevance of cultures of catheter-drawn blood and heparin-lock fluid to diagnose infection in hematologic patients.

Authors:  H F Guiot; A V Helmig-Schurter; J M van 't Noordende
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

9.  Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.

Authors:  S de Marie; P J van den Broek; R Willemze; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.